Aktienanalyse zu FitLife Brands Inc (FTLF)FTLFFitLife Brands Inc

FitLife Brands, Inc. is a developer and marketer proprietary nutritional supplements and wellness products for health-conscious consumers. It markets approximately 250 different products primarily online, through domestic and international GNC franchise locations as well as through various retail locations. It offers NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, and Metis Nutrition (together, NDS Products); iSatori, BioGenetic Laboratories, and Energize (together, the iSatori Products); Dr. Tobias, All Natural Advice, and Maritime Naturals (together, the MRC Products) and MusclePharm. Its NDS brand includes premium weight loss, sports nutrition, and general health products. Its PMD brand includes premium sports nutrition products. Its Nutrology brand included sports nutrition and general wellness products with an emphasis on natural, vegan, and organic ingredients. Its SirenLabs brand includes weight loss and sports nutrition products. It operates in the Consumer Non-Cyclicals sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

FitLife Brands Inc is currently not a good buy due to its low RSI of 35.56, indicating oversold conditions, and a significant year-to-date price decline of 37.91%. While there is potential for recovery with a projected price target of $17 to $18 from analysts, the current market sentiment and performance metrics suggest caution.